JS4-30341-12098 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-10-08
Dose 1 — Moderna
2021-10-11
Registered in v-safe
2021-10-11
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2021-10-12
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school

Adult check-in
2021-10-13
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Itching · Rash, not including the immediate area around the injection site

Adult check-in
2021-10-15
Health check-in — day 7, dose 1
Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-10-22
Survey response — day 14, dose 1
MedDRA: Asthma, Dermatitis allergic, Insomnia, Migraine — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Severe allergies to my neck, face and back. Asthma, migranes and unable to sleep.

MedDRA releases: 2024-11 · check-in free text available
2021-10-22
Report sent to call center — day 14, dose 1
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-10-27
Call 1 — Left Voicemail
2021-10-27
Call successful
Participant prefers to complete VAERS report online
2021-10-29
Survey response — day 21, dose 1
MedDRA: Asthma — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Have to use neubulizer 2X per day for asthma now.

MedDRA releases: 2024-11 · check-in free text available
2021-10-29
Report sent to call center — day 21, dose 1
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-11-01
Call 2 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-10-08	Moderna	No

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 10 — day 14, dose 1

2021-10-22

Symptoms: Severe allergies to my neck, face and back. Asthma, migranes and unable to sleep.

Release 10 — day 21, dose 1

2021-10-29

Symptoms: Have to use neubulizer 2X per day for asthma now.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthma	·	·	✓
SD	Dermatitis allergic	·	·	✓
SD	Insomnia	·	·	✓
SD	Migraine	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release